Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2008-07-31
2009-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ophthalmic Compatibility During Seven Days of Continuous Wear of Silicone Hydrogel Lenses
NCT00934102
Three Daily Wear Monthly Replacement Silicone Hydrogel Contact Lenses With Two Multi-purpose Disinfecting Solution Combinations
NCT04789382
Overall Performance of a 1-day Silicone Hydrogel Lens When Habitual Soft Lens Wearers Are Refit
NCT02588573
Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses
NCT06461455
Clinical Comparison of Two Daily Wear Frequent Replacement Silicone Hydrogel Soft Contact Lenses
NCT04532099
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Purevision Lens with ReNu
Purevision Lenses with ReNu Multiplus Solution
Purevision Lenses with ReNu Multiplus
Purevision lenses using ReNu Multiplus lens solution for 28 days
Purevision Lenses with RepleniSH
Purevision Lenses with Optifree RepleniSH Solution
Purevision Lenses with Optifree RepleniSH
Purevision lenses using Optifree RepleniSH lens solution for 28 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Purevision Lenses with ReNu Multiplus
Purevision lenses using ReNu Multiplus lens solution for 28 days
Purevision Lenses with Optifree RepleniSH
Purevision lenses using Optifree RepleniSH lens solution for 28 days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Is correctable to a visual acuity of 6/7.5 (20/25) or better (both eyes) with their habitual vision correction;
* Is a current soft lens wearer and wears contact lenses six or more days/week;
* Has clear corneas and no active ocular disease.
Exclusion Criteria
* Has undergone corneal refractive surgery;
* Is aphakic;
* Has any active ocular disease;
* Has any systemic disease affecting ocular health;
* Is using any systemic or topical medications that may affect ocular health;
17 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bausch & Lomb Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Trefford Simpson, DipOptom,MSc,PhD
Role: PRINCIPAL_INVESTIGATOR
University of Waterloo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Waterloo
Waterloo, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P/289/07/B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.